株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

非侵襲性血糖モニタリング装置の世界市場:2019年~2023年

Non-invasive Glucose Monitoring Devices Market by Product and Geography - Global Forecast and Analysis 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 910733
出版日 ページ情報 英文 127 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.69円で換算しております。
Back to Top
非侵襲性血糖モニタリング装置の世界市場:2019年~2023年 Non-invasive Glucose Monitoring Devices Market by Product and Geography - Global Forecast and Analysis 2019-2023
出版日: 2019年09月06日 ページ情報: 英文 127 Pages
概要

非侵襲性血糖モニタリングデバイス市場は、糖尿病の有病率の増加や政府プログラムの増加、製品の発表、非侵襲的処置の需要の増加などが成長促進要因となり、予測期間中に11%以上のCAGRで拡大する見込みです。ただし、精度の問題による製品の市場からの撤退、非侵襲性血糖モニタリング装置に関連する高コスト、従来の血糖測定器の激しい競争と強いプレゼンスなどの要因により、予測期間にわたって非侵襲性血糖モニタリング装置業界の成長が妨げられる可能性があります。

当レポートでは、世界の非侵襲性血糖モニタリング装置市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2018年)
  • 市場規模および予測(2018年~2023年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:製品別

  • 市場セグメンテーション:製品別
  • 製品別比較:市場規模および予測(2018年~2023年)
  • ウェアラブル装置
  • 非ウェアラブル装置
  • 市場機会:製品別

第7章 顧客情勢

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2018年~2023年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • 事業拡大のためのコラボレーションへの注目の高まり
  • 血糖モニタリングにおけるAIとRADAR技術の統合
  • 非侵襲性血糖モニタリング技術に対する財政支援の増加

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競争シナリオ

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Cnoga Medical Ltd.
  • Evia Medical Technologies
  • Helo Corp.
  • Integrity Applications Inc.
  • Nemaura Medical Inc.
  • RISE Life Science Corp.
  • Taiwan Biophotonic Co.

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

目次
Product Code: IRTNTR32011

About this market

Technavio's non-invasive glucose monitoring devices market analysis considers sales from products such as wearable devices and non-wearable devices. Our analysis also considers the sales of non-invasive glucose monitoring devices in Asia, Europe, North America, and ROW. In 2018, the wearable devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the increasing prevalence of diabetes, technological advancements, and new product launches will play a significant role in the wearable devices segment to maintain its market position. Also, our global non-invasive glucose monitoring devices market report looks at factors such as increasing prevalence of diabetes and growing number of government programs, product launches and increasing demand for non-invasive procedures. However, product withdrawal from the market due to accuracy issues, high costs associated with non-invasive glucose monitoring devices, and intense competition and strong presence of conventional blood glucometer may hamper the growth of the non-invasive glucose monitoring devices industry over the forecast period.

Overview

Increasing demand for non-invasive procedures

The demand for non-invasive monitoring and diagnostic procedures is increasing owing to their ease of operation, fewer side effects and minimum discomfort. Non-invasive glucose monitoring devices are increasingly being used as alternatives to conventional blood glucose monitoring devices as the latter method causes pain and discomfort to patients. Moreover, it provides real-time data that shows trends in glucose measurements and help in maintaining a standard glucose level by controlling diabetes and complications associated with it. This will lead to the expansion of the global non-invasive glucose monitoring devices market at a CAGR of over 11% during the forecast period.

Integration of AI and RADAR technology in glucose monitoring

The integration of AI and RADAR systems in diagnostic devices has revolutionized the medical industry. This has led the researcher to develop non-invasive glucose monitoring devices combining AI and RADAR technologies, which enables people with diabetes to monitor their blood glucose levels. Vendors are collaborating with IT companies for data management and the development of tools and software for easier diabetes management. Such technologies will eliminate the need for finger pricking. The integration of data received from digital medical devices with mobile applications allow customers to easily monitor body parameters, such as changes in glucose levels. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global non-invasive glucose monitoring devices market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global non-invasive glucose monitoring devices market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-invasive glucose monitoring devices manufacturers, that include Abbott Laboratories, Cnoga Medical Ltd., Evia Medical Technologies, Helo Corp., Integrity Applications Inc., Nemaura Medical Inc., RISE Life Science Corp., Taiwan Biophotonic Co.

Also, the non-invasive glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Wearable devices - Market size and forecast 2018-2023
  • Non-wearable devices - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing focus on collaborations for business expansion
  • Integration of AI and RADAR technology in glucose monitoring
  • Growing funding for non-invasive glucose monitoring technology

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Cnoga Medical Ltd.
  • Evia Medical Technologies
  • Helo Corp.
  • Integrity Applications Inc.
  • Nemaura Medical Inc.
  • RISE Life Science Corp.
  • Taiwan Biophotonic Co.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Product Overview
  • Exhibit 02: Global medical devices market
  • Exhibit 03: Segments of global medical devices market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Product - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Wearable devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Wearable devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Non-wearable devices - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Non-wearable devices - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2018-2023 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 30: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Vendor landscape
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Vendors covered
  • Exhibit 42: Vendor classification
  • Exhibit 43: Market positioning of vendors
  • Exhibit 44: Abbott Laboratories - Vendor overview
  • Exhibit 45: Abbott Laboratories - Business segments
  • Exhibit 46: Abbott Laboratories - Organizational developments
  • Exhibit 47: Abbott Laboratories - Geographic focus
  • Exhibit 48: Abbott Laboratories - Segment focus
  • Exhibit 49: Abbott Laboratories - Key offerings
  • Exhibit 50: Abbott Laboratories - Key customers
  • Exhibit 51: Cnoga Medical Ltd. - Vendor overview
  • Exhibit 52: Cnoga Medical Ltd. - Key offerings
  • Exhibit 53: Cnoga Medical Ltd. - Key customers
  • Exhibit 54: Evia Medical Technologies - Vendor overview
  • Exhibit 55: Evia Medical Technologies - Business segments
  • Exhibit 56: Evia Medical Technologies - Key offerings
  • Exhibit 57: Evia Medical Technologies - Key customers
  • Exhibit 58: Helo Corp. - Vendor overview
  • Exhibit 59: Helo Corp. - Key offerings
  • Exhibit 60: Helo Corp. - Key customers
  • Exhibit 61: Integrity Applications Inc. - Vendor overview
  • Exhibit 62: Integrity Applications Inc. - Organizational developments
  • Exhibit 63: Integrity Applications Inc. - Geographic focus
  • Exhibit 64: Integrity Applications Inc. - Key offerings
  • Exhibit 65: Integrity Applications Inc. - Key customers
  • Exhibit 66: Nemaura Medical Inc. - Vendor overview
  • Exhibit 67: Nemaura Medical Inc. - Organizational developments
  • Exhibit 68: Nemaura Medical Inc. - Key offerings
  • Exhibit 69: Nemaura Medical Inc. - Key customers
  • Exhibit 70: RISE Life Science Corp. - Vendor overview
  • Exhibit 71: RISE Life Science Corp. - Business segments
  • Exhibit 72: RISE Life Science Corp. - Organizational developments
  • Exhibit 73: RISE Life Science Corp. - Key offerings
  • Exhibit 74: RISE Life Science Corp. - Key customers
  • Exhibit 75: Taiwan Biophotonic Co. - Vendor overview
  • Exhibit 76: Taiwan Biophotonic Co. - Organizational developments
  • Exhibit 77: Taiwan Biophotonic Co. - Key offerings
  • Exhibit 78: Taiwan Biophotonic Co. - Key customers
  • Exhibit 79: Validation techniques employed for market sizing
  • Exhibit 80: Definition of market positioning of vendors
Back to Top